Submitted:
19 March 2025
Posted:
20 March 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Material and Methods
- ✓ Patients hospitalized for palliative care, without a diagnosis of pneumonia
- ✓ Under 65 years of age,
- ✓ Patients with missing data
- ✓ In the event of multiple ICU admissions during a hospital stay, only the first was included in the study.
3. Statistical Analysis
| 1. Very Fit: People who are vigorous, active and full of energy. They often exercise regularly. They are the most vigorous among their peers. | 6. Moderately Frail: Completely dependent on all outside-the-home activities and household chores. |
| 2.Good: No symptoms of active disease, but less vigorous than people in category 1. They exercise frequently or are occasionally very active. For example: Seasonal | 7. Severely Frail: Completely dependent on someone else for personal care for any reason (physical or cognitive). However, people who appear stable and are not at high risk of death (within about 6 months). |
| 3.Can Manage Well: These are people whose medical problems are under control and who are not active other than regular walking. | 8. Very Severely Frail: People who are completely dependent and are nearing the end of their lives. People who typically cannot recover from even a mild illness. |
| 4. Vulnerable: Although he is not dependent on others in his daily work, his movements are limited due to disease symptoms. Their general complaints are slowness and/or feeling tired throughout the day. | 9. Terminal Disease: People who are nearing the end of their lives. This category should be applied to those with a life expectancy of less than 6 months, even without being frail. |
| 5. Slightly Frail: More significant slowing down of movements, needing assistance in highly instrumental daily living activities (financial issues, transfer/travel, heavy housework, medication use). Typically, mild frailty progressively impairs ability to shop, walk outside alone, prepare meals, and do household chores. |
4. Results
5. Discussion
Author Contributions
Funding sources
Compliance with Ethical Standards
Ethics Committee Approval
Data Access Statement
Acknowledgments
Conflicts of Interest
References
- World Health Organization. “WHO clinical consortium on healthy ageing 2022: report of consortium meeting, 5–6 December 2022.” ; 2023.
- He W, Goodkind D, Kowal PR. An aging world: 2015. Washington, DC: United States Census Bureau; 2016.
- United Nations Department of Economic and Social Affairs. World Social Report 2023: Leaving No One Behind in an Ageing World. UN.; 2023.
- Cesari M, Prince M, Thiyagarajan JA, De Carvalho IA, Bernabei R, Chan P, et al. Frailty: An Emerging Public Health Priority. J Am Med Dir Assoc. 2016, 17, 188–92. [Google Scholar] [CrossRef] [PubMed]
- Bilir, N. Yaşlılık Tanımı, Yaşlılık Kavramı, Epidemiyolojik Özellikler, Yaşlılık ve Solunum Hastalıkları, ed. A. Ertürk, A. Bahadır, F. Koşar, TÜSAD, Türkiye Solunum Araştırmaları Derneği; 2018.
- Pel-Littel RE, Schuurmans MJ, Emmelot-Vonk MH, Verhaar HJJ. Frailty: defining and measuring a concept. J Nutr Heal Aging. 2009;13:390-4.
- Muscedere J, Waters B, Varambally A, Bagshaw SM, Boyd JG, Maslove D, et al. The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis. Intensive care medicine. 2017;43:1105-22.
- Fernando SM, McIsaac DI, Perry JJ, Rochwerg B, Bagshaw SM, Thavorn K, et al. Frailty and associated outcomes and resource utilization among older ICU patients with suspected infection. Critical Care Medicine 2019, 47, e669-76. [Google Scholar]
- Montgomery CL, Rolfson DB, Bagshaw SM. Frailty and the association between long-term recovery after intensive care unit admission. Critical care clinics. 2018, 34, 527–47. [Google Scholar] [CrossRef] [PubMed]
- Haas B, Wunsch H. How does prior health status (age, comorbidities and frailty) determine critical illness and outcome? Current opinion in critical care 2016, 22, 500–5. [Google Scholar] [CrossRef] [PubMed]
- Fried LP, Walston JD, Ferrucci L. Frailty In: Halter JB, Ouslander JG, Tinetti ME, et al., editors. Hazzard’s Geriatric Medicine and Gerontology. New York, NY: McGraw-Hill Medical; 2009. p. 631e645.
- Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. The lancet. 2013;381(9868):752-62.
- Lee JS, Auyeung TW, Leung J, Kwok T, Woo J. Transitions in frailty states among community-living older adults and their associated factors. Journal of the American Medical Directors Association. 2014;15(4):281-6.
- Hartley P, Adamson J, Cunningham C, Embleton G, Romero-Ortuno R. Clinical frailty and functional trajectories in hospitalized older adults: a retrospective observational study. Geriatrics & gerontology international. 2017;17(7):1063-8.
- Flaatten H, De Lange DW, Morandi A, Andersen FH, Artigas A, Bertolini G, et al. The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (>/= 80 years). Intensive Care Med. 2017;43(12):1820–8.
- Flaatten H, Guidet B, Andersen FH, Artigas A, Cecconi M, Boumendil A, et al. Reliability of the Clinical Frailty Scale in very elderly ICU patients: a prospective European study. Ann Intensive Care. 2021;11(1):22.
- Bruno RR, Wernly B, Bagshaw SM, van den Boogaard M, Darvall JN, De Geer L, et al. The Clinical Frailty Scale for mortality prediction of old acutely admitted intensive care patients: a meta-analysis of individual patient-level data. Annals of Intensive Care. 2023;13(1):37.
- Darvall JN, Bellomo R, Bailey M, Paul E, Young PJ, Rockwood K, et al. Frailty and outcomes from pneumonia in critical illness: a population-based cohort study. British Journal of Anaesthesia. 2020;125(5):730-8.
- Jung C, Bruno RR, Wernly B, Wolf G, Beil M, Kelm M. Frailty as a prognostic indicator inintensive care. Dtsch Arztebl Int. 2020;117(40):668–73.
- Remelli F, Scaramuzzo G, Capuzzo M, Maietti E, Berselli A, Denti M, et al. Frailty trajectories in ICU survivors: A comparison between the clinical frailty scale and the Tilburg frailty Indicator and association with 1 year mortality. J Crit Care. 2023;78:154398.
- Brummel NE, Bell SP, Girard TD, Pandharipande PP, Jackson JC, Morandi A, et al. Frailty and subsequent disability and mortality among patients with critical illness. American journal of respiratory and critical care medicine. 2017;196(1):64-72.
| n | % | ||
| Age group | Young elderly (65-74) |
190 | 39,7% |
| Middle-aged (75-84) |
175 | 36,6% | |
| Elderly (85 and over) |
113 | 23,6% | |
| Gender | Female | 205 | 43,0% |
| Male | 272 | 57,0% | |
| CFS group | 1-4 | 31 | 7,8% |
| 5-6 | 113 | 28,4% | |
| 7-8 | 254 | 63,8% | |
| Inotropic requirement | No | 347 | 72,6% |
| Yes | 131 | 27,4% | |
| 28-day mortality | No | 257 | 53,8% |
| Yes | 221 | 46,2% | |
| NIMV Days | MV Days | LOS ICU | LOS H | ||
| Age | r | -0,036 | -0,032 | 0,008 | -0,001 |
| p | 0,431 | 0,486 | 0,865 | 0,985 | |
| BMI | r | 0,053 | -0,063 | 0,020 | -0,042 |
| p | 0,245 | 0,166 | 0,665 | 0,364 | |
| CFS | r | -0,218 | 0,577 | 0,173 | -0,082 |
| p | <0,001 | <0,001 | <0,001 | 0,075 | |
| CCI | r | -0,138 | 0,128 | -0,041 | -0,090 |
| p | 0,002 | 0,005 | 0,373 | 0,049 | |
| APACHE II | r | -0,177 | 0,349 | 0,056 | -0,046 |
| p | <0,001 | <0,001 | 0,225 | 0,319 | |
| SOFA | r | -0,292 | 0,499 | 0,055 | -0,132 |
| p | <0,001 | <0,001 | 0,229 | 0,004 | |
| 28-Day Mortality | p | ||
|---|---|---|---|
| NO | YES | ||
| Med (Q1-Q3) | Med (Q1-Q3) | ||
| Age | 77,0(70,0-82,0) | 79,0(72,0-85,0) | 0,005 |
| BMI | 26,0(22,2-29,3) | 24,1(21,6-27,3) | 0,002 |
| CFS | 7,0(6,0-7,0) | 8,0(7,0-9,0) | <0,001 |
| CCI | 6,0(5,0-7,0) | 7,0(6,0-10,0) | <0,001 |
| APACHE II | 20,0(17,0-24,0) | 27,0(21,0-33,0) | <0,001 |
| SOFA | 5,0 (5,0-6,0) | 8,0(6,0-10,0) | <0,001 |
| NIMV duration | 1, (0-3,0) | 0 (0-1,0) | <0,001 |
| MV duration | 0(0-0) | 2,0(1,0-5,0) | <0,001 |
| LOS ICU | 3,0(2,0-6,0) | 4,0(2,0-8,0) | 0,111 |
| LOS H | 16,0(10,0-24,0) | 11,0(5,0-22,0) | <0,001 |
| CFS | p | |||
|---|---|---|---|---|
| 1-4 | 5-6 | 7-8 | ||
| Med (Q1-Q3) | Med (Q1-Q3) | Med (Q1-Q3) | ||
| NIMV duration | 1,3 (0-3) | 1,8(0-3) | 1,8(0-2) | 0,314Φ |
| MV duration | 0(0-0) | 0,7(0-0) | 3,8(0-3) | <0,001Φ |
| LOS ICU | 3(2-4) | 4,1(2-5) | 6,9(2-8) | 0,019Φ |
| LOS H | 15,3(7-21) | 17,8(10-23) | 18,2(8-24) | 0,123Φ |
| Inotropic requirement, n(%) | - | 9(8,0%) | 68(26,8%) | <0,001β |
| 28-day Mortality, n(%) | * | 20(17,7%) | 122(48,0%) | <0,001β |
| Univariate Logistic Regression | Multivariate Logistic Regression | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Wald | p | OR | 95% C.I.for OR | Wald | p | OR) | 95% C.I.for OR | |||
| Lower | Upper | Lower | Upper | |||||||
| Age | 7,093 | 0,008 | 1,032 | 1,008 | 1,056 | 5,088 | 0,024 | 1,021 | 1,009 | 1,050 |
| Gender | 1,229 | 0,268 | 1,229 | 0,854 | 1,769 | |||||
| BMI | 8,167 | 0,004 | 0,954 | 0,924 | 0,985 | 5,183 | 0,023 | 0,947 | 0,904 | 0,993 |
| CCI | 63,302 | <0,001 | 1,612 | 1,433 | 1,813 | 6,227 | 0,013 | 1,256 | 1,050 | 1,502 |
| APACHE II | 77,005 | <0,001 | 1,167 | 1,127 | 1,208 | 2,012 | 0,156 | 0,960 | 0,907 | 1,016 |
| SOFA | 103,183 | <0,001 | 2,849 | 2,328 | 3,486 | 47,175 | <0,001 | 2,452 | 1,898 | 3,166 |
| CFS | 107,597 | <0,001 | 3,520 | 2,775 | 4,464 | 42,971 | <0,001 | 2,533 | 1,919 | 3,345 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).